Aligos Therapeutics Inc
NASDAQ:ALGS

Watchlist Manager
Aligos Therapeutics Inc Logo
Aligos Therapeutics Inc
NASDAQ:ALGS
Watchlist
Price: 39.84 USD 3.89% Market Closed
Market Cap: 143m USD
Have any thoughts about
Aligos Therapeutics Inc?
Write Note

Wall Street
Price Targets

ALGS Price Targets Summary
Aligos Therapeutics Inc

Wall Street analysts forecast ALGS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALGS is 68.85 USD with a low forecast of 60.6 USD and a high forecast of 78.75 USD.

Lowest
Price Target
60.6 USD
52% Upside
Average
Price Target
68.85 USD
73% Upside
Highest
Price Target
78.75 USD
98% Upside
Aligos Therapeutics Inc Competitors:
Price Targets
688687
Beijing Kawin Technology Share-holding Co Ltd
68% Upside
NTRA
Natera Inc
14% Upside
300896
Imeik Technology Development Co Ltd
39% Upside
SIGHT
Gensight Biologics SA
40% Upside
002007
Hualan Biological Engineering Inc
20% Upside
IDYA
IDEAYA Biosciences Inc
118% Upside
LEGN
Legend Biotech Corp
147% Upside
SKYE
Skye Bioscience Inc
580% Upside

Revenue
Forecast

Revenue Estimate
Aligos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Aligos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Aligos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALGS's stock price target?
Price Target
68.85 USD

According to Wall Street analysts, the average 1-year price target for ALGS is 68.85 USD with a low forecast of 60.6 USD and a high forecast of 78.75 USD.

Back to Top